Stock 300760 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Stock

Equities

300760

CNE100003G67

Advanced Medical Equipment & Technology

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-21 pm EDT 		5-day change 1st Jan Change
278.5 CNY +2.63% Intraday chart for Shenzhen Mindray Bio-Medical Electronics Co., Ltd. +0.37% -4.15%
Apr. 17 Mindray Says It Is Compliant with International Trade Rules Ahead of EU Probe MT
Mar. 12 Nomura Adjusts Shenzhen Mindray Bio-Medical’s Price Target to 441.20 Yuan From 423.39 Yuan, Keeps at Buy MT

Financials

Sales 2023 * 35.56B 4.91B Sales 2024 * 42.7B 5.89B Capitalization 337B 46.49B
Net income 2023 * 11.63B 1.61B Net income 2024 * 13.98B 1.93B EV / Sales 2023 * 8.72 x
Net cash position 2023 * 26.59B 3.67B Net cash position 2024 * 33.82B 4.67B EV / Sales 2024 * 7.1 x
P/E ratio 2023 *
29 x
P/E ratio 2024 *
24.2 x
Employees 16,099
Yield 2023 *
1.94%
Yield 2024 *
2.39%
Free-Float 41.99%
More Fundamentals * Assessed data

Chart Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Dynamic Chart

Latest news about Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Mindray Says It Is Compliant with International Trade Rules Ahead of EU Probe MT
Nomura Adjusts Shenzhen Mindray Bio-Medical’s Price Target to 441.20 Yuan From 423.39 Yuan, Keeps at Buy MT
Majority of Shenzhen Stock Exchange-Listed Firms Post Profit Growth in 2023 MT
Mindray Bio-Medical to Buy Controlling Stake in Medical Devices Maker For 6.7 Billion Yuan MT
Chinese medical device firm Mindray plans $927 million deal to control APT Medical RE
Mindray Announces Five-Year Agreement with Wakemed Health & Hospitals CI
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Implements Profit Distribution for Third Quarter of 2023, Payable on 22 November 2023 CI
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Approves Profit Distribution Plan for Third Quarter 2023 CI
Listed Shenzhen Firms Post 7% Drop in Profit, 4% Rise in Revenue in January-September Period MT
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Proposes Cash Dividend for the Third Quarter of 2023 CI
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Nomura Adjusts Shenzhen Mindray Bio-Medical Electronics' Price Target to 423.39 Yuan From 476.95 Yuan, Keeps at Buy MT
Shenzhen Stock Exchange Launches SZSE 50 Index MT
Mindray Bio-Medical’s H1 Profit Jumps Nearly 22%; Revenue Misses Estimate MT
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
More news

Analyst Recommendations on Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Nomura Adjusts Shenzhen Mindray Bio-Medical’s Price Target to 441.20 Yuan From 423.39 Yuan, Keeps at Buy MT
Nomura Adjusts Shenzhen Mindray Bio-Medical Electronics' Price Target to 423.39 Yuan From 476.95 Yuan, Keeps at Buy MT
Nomura Adjusts Shenzhen Mindray Bio-Medical Electronics' Price Target to 476.95 Yuan From 462.72 Yuan, Keeps at Buy MT
Nomura Adjusts Shenzhen Mindray Bio-Medical Electronics' Price Target to 462.72 Yuan From 456.20 Yuan, Keeps at Buy MT
Nomura Adjusts Shenzhen Mindray Bio-Medical Electronics' Price Target to 456.20 Yuan From 450.54 Yuan, Keeps at Buy MT
More recommendations

Press releases Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Mindray Expands Its Cardiac Biomarker Portfolio with Cutting-Edge hs-cTnI and NT-proBNP Assays, Empowering Enhanced Cardiovascular Diseases Care AQ
Mindray and Operation Smile Begin 10-Year Partnership to Improve Healthcare for Vulnerable Communities AQ
Mindray Introduces New Wearable Patient Monitoring System, Refining Clinician’s Workflow to Track Patient Conditions BU
Mindray Showcases Hematology Innovations and Academic Achievements to the World at ISLH 2022 AQ
More press releases

News in other languages on Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Wird der CSI A50 zum besten chinesischen Index?
Wordt de CSI A50 de beste Chinese index?
Il CSI A50 diventerà il miglior indice cinese?
¿Se convertirá el CSI A50 en el mejor índice chino?
Le CSI A50 va-t-il devenir le meilleur indice chinois ?
More news

Quotes and Performance

1 day+2.63%
1 week+0.37%
Current month-1.04%
1 month-3.72%
3 months+1.34%
6 months+8.21%
Current year-4.15%
More quotes

Highs and lows

1 week
265.28
Extreme 265.28
281.21
1 month
257.00
Extreme 257
292.00
Current year
257.00
Extreme 257
307.10
1 year
253.48
Extreme 253.48
325.00
3 years
253.37
Extreme 253.37
502.00
5 years
130.00
Extreme 130
503.51
10 years
58.56
Extreme 58.56
503.51
More quotes

Managers and Directors - Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Managers TitleAgeSince
Hao Wu CEO
 Chief Executive Officer 52 17-01-04
Yun Zhao DFI
 Director of Finance/CFO 41 19-11-14
Yan Mei Guo BRD
 Director/Board Member 61 17-01-04
Members of the board TitleAgeSince
Hang Xu BRD
 Director/Board Member 62 99-01-24
Xi Ting Li CHM
 Chairman 73 17-01-04
Ming He Cheng BRD
 Director/Board Member 63 17-01-04
More insiders

ETFs positioned on Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Name Weight AuM 1st Jan change Investor Rating
KRANESHARES MSCI ALL CHINA HEALTH CARE INDEX UCITS ETF - USD ETF KraneShares MSCI All China Health Care Index UCITS ETF - USD
6.79% 2 M€ -20.02% -
More ETFs positioned on Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Quotes

Date Price Change Volume
24-04-22 278.5 +2.63% 4,584,429
24-04-19 271.4 -0.30% 3,267,198
24-04-18 272.2 -0.13% 4,111,948
24-04-17 272.6 +1.78% 4,692,098
24-04-16 267.8 -3.50% 9,294,146

End-of-day quote Shenzhen S.E., April 21, 2024

More quotes

Company Profile

Shenzhen Mindray Bio-Medical Electronics Co, Ltd. is one of the worldwide leading suppliers of medical devices and solutions. Products include patient monitoring and life support systems, in vitro diagnostics and medical imaging systems, orthopaedic implants, etc.
Sector
Advanced Medical Equipment & Technology
Calendar
2024-04-26 - Q1 2024 Earnings Release
More about the company

Income Statement Evolution

More financial data

Ratings for Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
278.5 CNY
Average target price
396.6 CNY
Spread / Average Target
+42.39%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-4.15% 46.5B
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+3.31% 209B
DANAHER CORPORATION Stock Danaher Corporation
+2.05% 175B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+9.36% 131B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+17.66% 99.98B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
-2.17% 61.12B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+14.05% 52.34B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-3.68% 39.24B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+9.04% 38.47B
RESMED, INC. Stock ResMed, Inc.
+4.84% 26.49B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. 300760 Stock